Open navigation
Search
Search

Select your region

Life Sciences & Healthcare Law Firm in North Macedonia

We cover every area of Life Sciences & Healthcare Law.

Latest

  • Medical technologies in defence and aerospace: Key themes and emerging questions in regulation
    09 Jan 2026 7 min read
  • Positive and negative pointers in clinical trial prior art: diverging inventive step outcomes at the EPO and UPC
    08 Jan 2026 13 min read

With over 480 international specialist lawyers across CMS and the support of the Life Sciences Asia-Pacific Network (LAN), we understand the scientific and commercial as well as the legal imperatives affecting your life sciences & healthcare business. We work with and have established long-term relationships with the top 100 life sciences & healthcare companies in the areas of pharmaceuticals, medical devices, biotechnology, agriculture and food, including the top 20 global pharmaceutical companies and nine out of the top ten global medical device companies.

Our experts, many of whom have worked in-house in your sector, have developed a shared capability in the areas of pharmaceuticals, biotechnology, medical devices and diagnostics. With active memberships in major industry associations we help shape the legal frameworks impacting the life sciences & healthcare sector.

We regularly advise our clients on their day-to-day operational needs such as support with advertisement and promotion of medicine, public sector procurement, pricing and reimbursement, patent enforcement, commercial and clinical trial agreements as well as regulatory advice and compliance. Equally, when you need life sciences & healthcare specialist advice for strategic agreements, planning a corporate transaction or embarking on litigation (whether product liability or otherwise), we have a team that is well versed in the industry issues to help you.

Life Sciences & Healthcare Insights

CMS Expert Guide to advertising of medicines and medical devices

26 Mar 2026 2 min read

Medical technologies in defence and aerospace: Key themes and emerging questions in regulation

09 Jan 2026 7 min read

Positive and negative pointers in clinical trial prior art: diverging inventive step outcomes at the EPO and UPC

08 Jan 2026 13 min read

Digital health apps and telemedicine: Updated CMS Expert Guide for 30 jurisdictions

01 Dec 2025 2 min read

A phase III clinical trial protocol does not by itself provide a reasonable expectation of success of the investigated treatment (T 122/23)

20 Aug 2025 15 min read

Technology Transformation: Life Sciences and Healthcare

29 Jul 2025 2 min read

China retaliates against EU by limiting procurement of EU medical devices

11 Jul 2025 5 min read

Defining a patient population based on clinical trial results (T 2481/22)

25 Jun 2025 9 min read

Events

  • North Macedonia
    08 Apr 2026

    CMS at Fordham IP & Policy Conference

  • North Macedonia
    21 Apr 2026

    On the Pulse webinar series 2026 - Spring/Summer

  • North Macedonia
    28 Apr 2026

    IP Insights webinar series 2026

  • North Macedonia
    02 May 2026

    CMS at INTA 2026

Back to top Back to top
Warning: Fraudulent emails and messages